Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Valeo Pharma Inc T.VPH.DB


Primary Symbol: T.VPH Alternate Symbol(s):  VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Opinion & Analysis (TSX:VPH)

    Valeo Pharma, CureVac, Moderna, Sartorius: high-flyers or latecomers?

    Nico Popp December 9, 2020

    BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results

    Mario Hose September 29, 2020

    BioNTech, CureVac, or Valeo Pharma: who brings the highest return to shareholders?

    Mario Hose September 23, 2020

    BioNTech, CureVac, Valeo Pharma - Growth after capital injection

    Mario Hose September 11, 2020

    Desert Gold, dynaCERT, Valeo Pharma - good news and the right time

    Mario Hose September 3, 2020

    Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

    Fredrick William  September 2, 2020

    BioNTech, CureVac, Valeo Pharma - COVID-19 wakes up the industry

    Mario Hose September 1, 2020

    BioNTech, CureVac, Valeo Pharma - the license to print money

    Mario Hose August 24, 2020

    Valeo Pharma bringing to market drug undergoing clinical trials to improve survival of COVID-19

    James O'Rourke May 22, 2020

    Valeo Pharma Big Pharma Capabilities Presents Opportunity

    Fredrick William  May 15, 2020